Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

AGM Result

22 Jun 2007 10:45

For Immediate Release 22 June 2007 LiDCO Group Plc ('the Company') Result of Annual General Meeting

LiDCO, the UK based, AIM-quoted cardiovascular monitoring company is pleased to announce that all resolutions proposed at the Annual General Meeting, held on 21 June 2007 at 11:00am were duly passed.

- ENDS -

For more information please contact:

LiDCO Group Plc Tel: +44 (0)20 7749 1500

Terry O'Brien - Chief Executive

Buchanan Communications Tel: +44 (0)20 7466 5000

Tim Anderson, James StrongNotes for EditorsAbout LiDCO Group Plc

LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients. Use of LiDCO's technology has been shown to significantly reduce the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. For more information please see www.lidco.com.

The Company's manufacturing facility is in Hoxton, London and its current products are:

* LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume;

* LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner.

* LiDCOview - software product for use on a PC: designed to aide clinical audit, teaching and research activities.

* LiDCOlive - software product in development for the remote display of hemodynamic monitoring parameters derived through use of the LiDCOplus monitor.

Distribution Network:

The Company has now achieved registration of its products in 14 markets in Europe, the USA, Brazil, South Korea and Japan. It sells direct in the UK and USA, and elsewhere through a worldwide network of specialty critical care distributors.

LIDCO GROUP PLC
Date   Source Headline
26th Jan 20064:38 pmPRNConvertible loan update
19th Jan 20067:00 amRNSProduct Development
19th Dec 20051:15 pmPRNResignation of a Director
8th Dec 20059:02 amPRNDirector Shareholding
18th Nov 20057:00 amRNSConversion of Loan
8th Nov 20057:01 amRNSPositive Study Data
3rd Nov 20057:00 amRNSUS Army Order
25th Oct 20057:01 amRNSClinical Advisory Board
18th Oct 20057:01 amRNSInterim Results
14th Oct 20051:39 pmPRNDirectorate Change
26th Sep 20059:11 amRNSNotice of Results
11th Aug 20057:02 amRNSUSD 2 Million Financing
14th Jul 20057:00 amRNSAdditional Listing
7th Jul 20057:01 amRNSNew Veterinary Application
23rd Jun 20054:00 pmRNSImpact of Review Paper
17th Jun 20057:00 amRNSBoard Appointment
16th Jun 20052:57 pmRNSAGM Statement
6th Jun 20052:38 pmPRNDirector Shareholding
1st Jun 20057:00 amRNSPositive Data
10th May 20052:20 pmPRNDirector Shareholding
9th May 20057:00 amRNSRegistration in Brazil
25th Apr 20057:00 amRNSAppointment of New Director
15th Apr 200511:46 amRNSDirector Shareholding
13th Apr 20057:00 amRNSDirector Share Options Award
7th Apr 20057:00 amRNSDirector Shareholding
30th Mar 20057:01 amRNSPreliminary Results
30th Mar 20057:01 amRNSProduct Approval in Denmark
24th Mar 20057:02 amRNSLaunch Of Software Upgrade
23rd Mar 200510:50 amPRNAdditional Listing
21st Mar 20057:02 amRNSSignificant Trial Results
15th Mar 20057:02 amRNSEuropean Approval
2nd Mar 20058:19 amRNSChange of Financial PR Agency
14th Feb 20057:00 amPRNMajor Clinical Trial
24th Jan 20053:25 pmPRNAdditional Listing
19th Jan 20054:16 pmPRNDirectorate Change
13th Jan 200511:28 amPRNAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.